This inventor holds 1 USPTO granted patent. Top assignee: Eastman-Kodak Company. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Yihsing Shih: Innovator in Antibody Detection Technology
Introduction
Yihsing Shih is a notable inventor based in San Mateo, California. He has made significant contributions to the field of diagnostic assays, particularly in the detection of antibodies. His innovative work has led to the development of a unique diluent composition that enhances the sensitivity and speed of antibody detection in biological specimens.
Latest Patents
Yihsing Shih holds a patent for a diluent composition useful in the detection of antibodies in assays. This patent describes a diluent and wash composition that is particularly effective for detecting retroviral antibodies. The diluent composition is buffered to a pH of 6 to 10 and includes a protein or carbohydrate, a surfactant, and a negatively-charged organic compound. The wash composition is buffered to a pH of 5 to 10 and also includes a surfactant. These compositions can be incorporated into diagnostic kits, facilitating the detection of antibodies through a method that involves mixing the biological specimen with the diluent composition, forming an immunological complex, and separating complexed materials from uncomplexed materials.
Career Highlights
Yihsing Shih is associated with Eastman Kodak Company, where he has applied his expertise in developing innovative solutions for antibody detection. His work has been instrumental in advancing diagnostic technologies that are crucial for medical testing and research.
Collaborations
Throughout his career, Yihsing Shih has collaborated with notable colleagues, including Margaret J Smith-Lewis and Harold C Warren. These collaborations have contributed to the development of effective diagnostic methods and technologies.
Conclusion
Yihsing Shih's contributions to the field of antibody detection exemplify the impact of innovation in medical diagnostics. His patented technology represents a significant advancement in the ability to detect antibodies quickly and accurately.
